Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CVS/Caremark deal closes

This article was originally published in The Tan Sheet

Executive Summary

CVS and Caremark announce March 22 they have closed their merger. The combined company renamed CVS/Caremark Corporation will "commence a cash tender offer in approximately five business days for $150 mil. or about 10 percent of its outstanding shares at a fixed price of $35 per share," according to a release. The combined company will trade on the NYSE under the symbol CVS, according to the firms. Caremark announced Jan. 7 its planned merger with CVS (1"The Tan Sheet" Jan. 15, 2007, In Brief). Also on March 22, CVS/Caremark announces its board of directors. The 14-member board was evenly split among designees from CVS and from Caremark, the company says in a release. Thomas M. Ryan will continue to serve as president and CEO...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100333

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel